Supplementary Figure S2 from First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors
Authors:
- Mark YarchoanMYMark Yarchoan
- John D. PowderlyJPJohn D. Powderly
- Bruno R. BastosBBBruno R. Bastos
- Thomas B. KarasicTKThomas B. Karasic
- Oxana V. CryslerOCOxana V. Crysler
- Pamela N. MunsterPMPamela N. Munster
- Meredith A. McKeanMMMeredith A. McKean
- Leisha A. EmensLELeisha A. Emens
- Yvonne M. SaengerYSYvonne M. Saenger
- Yasser GedYGYasser Ged
- Robert StaggRSRobert Stagg
- Steven SmithSSSteven Smith
Open Access
- 18 April 2024
- other
- Published by American Association for Cancer Research (AACR)